Oracle has made a minor investment in Proteus Digital Health, a company that makes ingestible and wearable sensors.

After years of using its digital health feedback system in clinical trials and studies, Proteus Digital Health, and partner Otsuka Pharmaceuticals, are poised to launch the first mass market drug to ...

Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a med ...

That sensor and patch record when the pill was taken and how your body responds, as measured by your heart rate, respiration, body angle, temperature, or even how many steps you’ve taken.

Proteus Digital Health—makers of an ingestible sensor embedded within a pill to track medication usage—has filed for bankruptcy, after failing to raise funding in part due to the COVID-19 ...

Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...

Proteus Digital Health created an ingestible sensor that monitors your medication intake.

Proteus Biomedical will receive $24 million worth of cash and equity investments up front as part of an exclusive, worldwide license and collaboration agreement with Novartis to develop ...

Proteus Digital Health has announced it has received FDA clearance for an ingestible sensor, according to a news release. The ingestible sensor, formally referred to as the Ingestion Event Marker, can ...